Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Vardenafil
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Chemical compound}} {{cs1 config|name-list-style=vanc|display-authors=6}} {{Use mdy dates|date=March 2024}} {{Drugbox | verifiedrevid = 458460083 | IUPAC_name = 4-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-9-methyl-7-propyl-3,5,6,8-tetrazabicyclo[4.3.0]nona-3,7,9-trien-2-one | image = Vardenafil structure.svg | width = 250 <!--Clinical data--> | tradename = Levitra, Staxyn, Vivanza | Drugs.com = {{drugs.com|monograph|vardenafil-hydrochloride}} | MedlinePlus = a603035 | pregnancy_AU = B3 | licence_EU = yes | routes_of_administration = [[Oral administration|By mouth]] | ATC_prefix = G04 | ATC_suffix = BE09 | ATC_supplemental = | legal_AU = S4 | legal_UK = POM | legal_US = Rx-only | legal_US_comment = <ref name="Levitra FDA label">{{cite web | title=Levitra (vardenafil hydrochloride) tablets, for oral use Initial U.S. Approval: 2003 | website=DailyMed | url=https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=595067 | access-date=April 3, 2023}}</ref> | legal_status = Rx-only <!--Pharmacokinetic data--> | bioavailability = 15% | protein_bound = 95% | metabolism = [[Liver]] ([[CYP3A4]]) | elimination_half-life = 4β5 hours | excretion = [[Bile duct]] <!--Identifiers--> | IUPHAR_ligand = 7320 | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 224785-90-4 | PubChem = 110634 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00862 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 99300 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = UCE6F4125H | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 1520 | KEGG = D08668 <!--Chemical data--> | C=23 | H=32 | N=6 | O=4 | S=1 | smiles = O=C2\N=C(/Nn1c(nc(c12)C)CCC)c3cc(ccc3OCC)S(=O)(=O)N4CCN(CC)CC4 | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30) | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = SECKRCOLJRRGGV-UHFFFAOYSA-N }} [[File:Sexual enhancer (phosphodiesterase-5 inhibitors) - Vardenafil - Aristo Pharma - Vardenaristo - 4 tablets Blister 20 mg - Image 002.jpg|thumb|Vardenafil 4 tablets Blister 20 mg]] '''Vardenafil''', sold under the brand name '''Levitra''' among others, is a [[medication]] that is used for treating [[erectile dysfunction]].<ref name="Levitra FDA label" /><ref>{{cite web|url=https://deutschemedz.de/levitra/|title=Levitra (Vardenafil) is A Drug Used to Treat Erectile Problems in Men|access-date=May 12, 2010|publisher=Deutschemedz|language=de}}</ref> It is a [[PDE5 inhibitor]].<ref name="Levitra FDA label" /> It is taken [[by mouth]].<ref name="Levitra FDA label" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)